Home / Share Price Target / Fredun
Fredun Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Fredun Pharmaceuticals Limited | |||
 | Symbol: FREDUN | ||
| Price: ₹672 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Fredun Pharmaceuticals Financial Performance
- 0.1.1: Is Fredun Pharmaceuticals A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Fredun Pharmaceuticals Share Price Target For 2024
- 1.1.1: Fredun Pharmaceuticals Share Price Target Table For 2024
- 1.1.2: Summary: Fredun Pharmaceuticals Share Price Prediction For 2024
- 1.2: Fredun Pharmaceuticals Share Price Target For 2025
- 1.2.1: Fredun Pharmaceuticals Share Price Target Table For 2025
- 1.2.2: Summary: Fredun Pharmaceuticals Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Fredun Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Fredun Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Fredun Pharmaceuticals Past Performance
Fredun Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 275.22 Crore | Market valuation of Fredun Pharmaceuticals's shares. |
| Revenue (TTM) | 346.57 Crore | Total revenue generated by Fredun Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +15.62 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 9.8% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 20.66% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +37.86% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 1.04 | Company's total debt divided by total shareholder equity. |
| Total Debt | 137.15 Crore | Sum of Fredun Pharmaceuticals's current & long-term financial obligations. |
Is Fredun Pharmaceuticals A Good Buy For Long Term?
Fredun Pharmaceuticals, a small-cap stock with a market capitalization of ₹268.1 crore, presents a mixed picture for long-term investors. While its revenue (₹346.57 crore TTM) and net profit (₹15.62 crore TTM) are positive, a significant debt of ₹137.15 crore (Q2 2024-25) raises concerns. Although the past 5-year returns (99.34%) are impressive, recent performance is weak (-22.65% YTD, -28.36% over 6 months). Considering the substantial debt and negative recent returns, Fredun Pharmaceuticals is currently a not a good buy for long-term investors. Further due diligence is strongly recommended.
To predict the Fredun Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Fredun Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Fredun Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fredun Pharmaceuticals shares in 2024, see the table below.
Fredun Pharmaceuticals Share Price Target Table For 2024
| Fredun Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 695.00 (+3.42%) | Price Action: Nov 2024 High |
| 2024 Target 2 | 686.00 (+2.08%) | Price Action: 29 Oct 2024 Low |
| 2024 Target 1 | 679.00 (+1.04%) | Price Action: 19 Nov 2024 Low |
| Current Price | 672.00 | Fredun Pharmaceuticals's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 668.58 (-0.51%) | Fibonacci Retracement Level 71.8% |
| Stop Loss 2 | 658.72 (-1.98%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 3 | 650.00 (-3.28%) | Price Action: Mar 2024 Low |
Summary: Fredun Pharmaceuticals Share Price Prediction For 2024
In summary, Fredun Pharmaceuticals has declined by ₹-196.75, recording a notable -22.65% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Fredun Pharmaceuticals for 2024 predicts an additional rise of 1.04% to 3.42% by the end of 2024 with three potential targets T1: 679.00, T2: 686.00, T3: 695.00. Stop Loss at SL1: 668.58, SL2: 658.72, SL3: 650.00.
Fredun Pharmaceuticals has a 52-week high of ₹1054.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹650.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Fredun Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Fredun Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Fredun Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fredun Pharmaceuticals shares in 2025, see the table below.
Fredun Pharmaceuticals Share Price Target Table For 2025
| Fredun Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 961.47 (+43.07%) | Price Action: Chart |
| 2025 Target 2 | 943.54 (+40.4%) | Price Action: Chart |
| 2025 Target 1 | 934.20 (+39.01%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 672.00 | Fredun Pharmaceuticals's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 597.00 (-11.17%) | Price Action: Mar 2021 High |
| Stop Loss 2 | 591.03 (-12.05%) | Price Action: Chart |
| Stop Loss 3 | 577.00 (-14.14%) | Price Action: Feb 2021 High |
Summary: Fredun Pharmaceuticals Share Price Prediction For 2025
In summary, Fredun Pharmaceuticals has declined by ₹-196.75, recording a notable -22.65% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Fredun Pharmaceuticals for 2025 predicts an additional rise of 39.01% to 43.07% by the end of 2025 with three potential targets T1: 934.20, T2: 943.54, T3: 961.47. Stop Loss at SL1: 597.00, SL2: 591.03, SL3: 577.00.
Fredun Pharmaceuticals has a All-Time high of ₹1428.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹650.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Fredun Pharmaceuticals, we have created a specific page for that check here: Fredun Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Fredun Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Fredun Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.1% over the next 15 years.
For complete year by year Fredun Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Fredun Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Fredun Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹672 | [Current Price] |
| 2024 | ₹598.96 | -10.87% |
| 2025 | ₹485.68 | -18.92% |
| 2026 | ₹571.62 | 17.69% |
| 2027 | ₹541.71 | -5.24% |
| 2028 | ₹593.62 | 9.58% |
| 2029 | ₹533.36 | -10.16% |
| 2030 | ₹575.8 | 7.95% |
| 2031 | ₹670.94 | 16.52% |
| 2032 | ₹649.84 | -3.15% |
| 2033 | ₹632.98 | -2.6% |
| 2034 | ₹602.41 | -4.83% |
| 2035 | ₹608.28 | 0.97% |
| 2036 | ₹553.88 | -8.95% |
| 2037 | ₹715.29 | 29.14% |
| 2038 | ₹712.48 | -0.4% |
| 2039 | ₹698.51 | -1.97% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Fredun Pharmaceuticals Past Performance
- In 2016, Fredun Pharmaceuticals opening price was ₹12.5
- As of Thu 21 Nov 2024 the price stands at ₹672.
- This represents a Compound Annual Growth Rate (CAGR) of 55.69%.
- In 8 years, an investment of 10,000 would have become ₹5.37 Lakh.
As we wrap up, we hope you like our study on Fredun Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Fredun Pharmaceuticals Share Price History
- Fredun Pharmaceuticals Price Target Tomorrow
- Fredun Pharmaceuticals Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
